Status:
UNKNOWN
Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)
Lead Sponsor:
Beijing Center for Disease Control and Prevention
Conditions:
Adverse Reaction to Drug
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The investigators would remind the guardians of observation after immunization via sending short message and collect the information of AEFI by two ways, short message/telephone and website questionna...
Detailed Description
The investigators will compare the rate between active and inactive surveillance of AEFI
Eligibility Criteria
Inclusion
- According with the regular vaccination
- Immunization the acellular pertussis diphtheria tetanus vaccine and Measles and rubella combined vaccine
Exclusion
- Disapproval the AEFI information
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2014
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01830257
Start Date
April 1 2013
End Date
June 1 2014
Last Update
April 12 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.